VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 55 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,134,189 | -34.1% | 146,347 | -2.6% | 0.00% | – |
| Q2 2023 | $1,720,546 | -60.9% | 150,266 | -73.7% | 0.00% | -100.0% |
| Q1 2023 | $4,399,195 | +252.5% | 570,583 | +178.9% | 0.00% | – |
| Q4 2022 | $1,248,054 | -32.2% | 204,599 | -34.2% | 0.00% | – |
| Q3 2022 | $1,840,000 | -10.3% | 310,876 | -10.5% | 0.00% | – |
| Q2 2022 | $2,052,000 | -24.7% | 347,253 | -2.9% | 0.00% | – |
| Q1 2022 | $2,725,000 | +54.5% | 357,600 | -45.1% | 0.00% | – |
| Q4 2021 | $1,764,000 | +1489.2% | 650,984 | +1432.9% | 0.00% | – |
| Q3 2021 | $111,000 | -87.2% | 42,468 | -79.7% | 0.00% | – |
| Q2 2021 | $866,000 | -7.2% | 209,397 | +5.7% | 0.00% | – |
| Q1 2021 | $933,000 | -43.2% | 198,196 | -13.8% | 0.00% | – |
| Q4 2020 | $1,644,000 | +313.1% | 229,876 | +516.6% | 0.00% | – |
| Q3 2020 | $398,000 | -16.9% | 37,282 | -1.7% | 0.00% | – |
| Q2 2020 | $479,000 | +35.3% | 37,933 | -1.8% | 0.00% | – |
| Q1 2020 | $354,000 | -43.6% | 38,643 | -14.2% | 0.00% | – |
| Q4 2019 | $628,000 | -48.2% | 45,048 | -36.1% | 0.00% | – |
| Q3 2019 | $1,213,000 | -89.2% | 70,500 | -83.0% | 0.00% | -100.0% |
| Q2 2019 | $11,275,000 | +645.7% | 414,194 | +424.3% | 0.00% | – |
| Q1 2019 | $1,512,000 | +317.7% | 79,000 | +105.2% | 0.00% | – |
| Q4 2018 | $362,000 | -56.9% | 38,507 | -13.3% | 0.00% | – |
| Q3 2018 | $840,000 | -49.6% | 44,400 | -47.9% | 0.00% | – |
| Q2 2018 | $1,666,000 | -15.0% | 85,300 | -18.3% | 0.00% | – |
| Q1 2018 | $1,961,000 | -31.5% | 104,400 | -39.5% | 0.00% | – |
| Q4 2017 | $2,863,000 | -4.3% | 172,476 | +18.6% | 0.00% | -100.0% |
| Q3 2017 | $2,993,000 | +1157.6% | 145,397 | +677.3% | 0.00% | – |
| Q4 2016 | $238,000 | – | 18,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |